Comparing the current results to its competitors, Can B reported Revenue decrease in the 3 quarter 2024 year on year by -96.36 %, despite the revenue increase by the most of its competitors of 16.16 %, recorded in the same quarter.
Can B 's Comment on Competition and Industry Peers
The CBD and cannabis markets are competitive, comprising a range of companies from small operations to large conglomerates with varying levels of experience, capital, and industry knowledge. The company emphasizes third-party independent testing and transparency by publishing lab results online. Among the largest CBD companies identified are Elixinol LLC (UK, $37 million revenue), GW Pharmaceuticals (UK, $19 million revenue), and Aurora Cannabis (Canada, just over $19 million revenue). Leading U.S. companies include Medical Marijuana ($59 million revenue), CV Sciences ($48 million revenue), Gaia Herbs ($45 million revenue), and Charlotte’s Web ($17 million revenue). In 2019, the company acquired assets from former competitor Seven Chakras, LLC. Competitors referenced in company filings include Aurora Cannabis, Charlotte’s Web, CV Sciences, Elixinol LLC, Gaia Herbs, GW Pharmaceuticals, Medical Marijuana, and Seven Chakras, LLC.
Aurora Cannabis Inc operates as a vertically integrated cannabis company, controlling every aspect of the supply chain from cultivation to distribution. They focus on producing and selling medical and recreational cannabis products globally. This business model allows them to have greater control over product quality, streamline operations, and capitalize on the growing market for cannabis.
Cronos Group Inc operates as a vertically integrated cannabis company. Their business model revolves around cultivating, manufacturing, and distributing medical and recreational cannabis products. They aim to capture market share through their unique brands and partnerships with influential companies in various sectors.
Tilray Brands Inc operates as a cannabis-focused consumer packaged goods company. They develop and market a range of cannabis products, including dried flower, oils, capsules, and beverages, catering to medical and recreational users. With a focus on innovation and brand-building, Tilray Brands Inc aims to establish a strong presence in the cannabis industry and deliver high-quality products to its customers.
Sources:
Can B Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Can B Corp versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
